Innovent Biologics Inc (6IB) — Cash Flow Quality Index
Innovent Biologics Inc (6IB) has a Cash Flow Quality Index of 12.29x as of December 2025. Operating cash flow of €10.00 Billion exceeds net income of €813.57 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow conversion of Innovent Biologics Inc to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Innovent Biologics Inc Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Innovent Biologics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 6IB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Innovent Biologics Inc (2025–2025)
Year-by-year earnings quality comparison for Innovent Biologics Inc. For live market cap and the full company financial profile, see Innovent Biologics Inc market cap and net worth.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 12.29x | €10.00 Billion | €813.57 Million | — |